Concepedia

Publication | Open Access

Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial

DOIFull Paper Access

442

Citations

30

References

2019

Year

Richard Furie, Eric F. Morand, Ian N Bruce, Susan Manzi, Kenneth Kalunian, Edward M Vital, Theresa Lawrence Ford, Ramesh K. Gupta, Falk Hiepe, Mittermayer B. Santiago,
The Lancet Rheumatology

References

YearCitations

Page 1